US Patent 8097599 Plasmid encoding feline BMP-7

Patent 8097599 was granted and assigned to Merial on January, 2012 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Merial

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

8097599

Date of Patent

January 17, 2012

Patent Application Number

12794184

Date Filed

June 4, 2010

Patent Citations Received

‌

US Patent 11905531 Recombinant AAV vectors expressing osteoprotective genes, including HAS2 and lubricin, useful in the treatment of osteoarthritis and related joint conditions in mammals

Patent Primary Examiner

‌

Michael C. Wilson

Patent abstract

The present invention relates to recombinant vectors expressing the BMP-7 polypeptide in host cells and to pharmaceutical compositions comprising such recombinant vectors. The invention also encompasses methods for prevention and/or treatment of both acute and chronic renal failure in mammals, advantageously in humans, dogs and cats, by intra-vascular kidney administration of the recombinant vectors and pharmaceutical compositions of the invention.